Carbetocin vs. oxytocin at elective caesarean delivery: a reply
- PMID: 37443428
- DOI: 10.1111/anae.16094
Carbetocin vs. oxytocin at elective caesarean delivery: a reply
Comment on
-
Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial.Anaesthesia. 2023 Oct;78(10):1306-1307. doi: 10.1111/anae.16066. Epub 2023 Jun 19. Anaesthesia. 2023. PMID: 37337425 No abstract available.
References
-
- Hughes IP, Butler S. Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial. Anaesthesia 2023; 78: 1306-7.
-
- McDonagh F, Carvalho JCA, Abdulla S, et al. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens. Anaesthesia 2022; 77: 892-900.
-
- Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstetrics and Gynecology 2004; 104: 1005-1010.
-
- Khan M, Balki M, Ahmed I, Farine D, Seaward G, Carvalho JC. Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose. Canadian Journal of Anaesthesia 2014; 61: 242-248.
-
- Rosseland LA, Hauge TH, Grindheim G, Stubhaug A, Langesaeter E. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology 2013; 119: 541-551.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources